Marc Arbyn

20.8k citations

168 papers · 12.9k indexed · 8 hit papers · h-index 45

Impact in

Epidemiology top 0.05%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments

Papers in

Epidemiology 153
- Cervical Cancer and HPV Research 149
- Hepatitis B Virus Studies 28
Microbiology 27
- Reproductive tract infections research 26

Co-authors: Victoria Nyawira Nyaga Marc Aerts Freddie Bray Laia Bruni Elisabete Weiderpass Sílvia de Sanjosé Mona Saraiya Jacques Ferlay
Journals: Journal of Clinical Virology (16 papers)International Journal of Cancer (12 papers)Journal of Clinical Microbiology (7 papers)Journal of Medical Virology (7 papers)Journal of Molecular Diagnostics (5 papers)
Partner nations: Belgium United Kingdom United States

In The Last Decade

Marc Arbyn

160 papers receiving 12.7k citations

Hit Papers

8 papers align trajectories log scale

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis 2023 · 142 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 The Lancet Global Health
2022 The Lancet Global Health
2019 The Lancet Global Health
2018 JAMA Internal Medicine
2018 BMJ
2016 BMJ
2014 Archives of Public Health
2013 The Lancet

Peers

Countries citing papers authored by Marc Arbyn

Since Specialization

Citations

This map shows the geographic impact of Marc Arbyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Arbyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Arbyn more than expected).

Fields of papers citing papers by Marc Arbyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Arbyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Arbyn. The network helps show where Marc Arbyn may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Arbyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Arbyn Line = papers co-authored together Marc Arbyn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples Journal of Molecular Diagnostics ·Severien Van Keer, Ardashel Latsuzbaia, Davy Vanden Broeck, P. De Sutter, Gilbert Donders, Jean Doyen, Wiebren Tjalma, Steven Weyers, Marc Arbyn, Alex Vorsters	2025	1
2	Clinical validation of the Roche cobas HPV test on the Roche cobas 6800 system for the purpose of cervical screening and qualification as a second-generation comparator test Journal of Virological Methods ·Marco Ho Ting Keung, Nikita Mehta, Elliott Lynn, E. Pineda, Dagnachew Fetene, Alvin Lee, Nick Vandegraaff, Terri Sahin, Alice Chynoweth, Cassandra Bonney, Hiu Tat Chan, Marc Arbyn, Marion Saville, David Hawkes	2025	1
3	The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical cancer screening program Contemporary Clinical Trials ·Eva Gezels, Kaatje Van Roy, Marc Arbyn, Patrick Coursier, Dirk Devroey, Patrick Martens, Cindy Simoens, Bert Vaes, Koen Van Herck, Patrik Vankrunkelsven, Véronique Verhoeven, Sara Willems	2024	0
4	Baseline assessment of cervical cancer screening and treatment capacity in 25 counties in Kenya, 2022 Frontiers in Oncology ·Valerian Mwenda, David Murage, Catherine Kilonzo, Joan‐Paula Bor, Patricia Njiri, Lance Osiro, Mary Nyangasi, Marc Arbyn, Philippe Tummers, Marleen Temmerman	2024	4
5	The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high‐risk HPV Journal of Medical Virology ·Jean‐Luc Prétet, Alice Baraquin, Pui Yan Jenny Chung, Line Puget, Sharonjit K. Dhillon, Yuliya Tkachenka, Killian Jacquot, Quentin Lepiller, Davy Vanden Broeck, Marc Arbyn	2024	1
6	Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework Journal of Molecular Diagnostics ·Ardashel Latsuzbaia, Davy Vanden Broeck, Severien Van Keer, Steven Weyers, Gilbert Donders, Jean Doyen, Wiebren Tjalma, P. De Sutter, Alex Vorsters, Marc Arbyn	2023	11
7	Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis British Journal of Cancer ·Laura Downham, Iman Jaafar, (unknown), Victoria Nyawira Nyaga, Joan Valls, Armando Baena, Li Zhang, Marc J. Gunter, Marc Arbyn, Maribel Almonte	2023	11
8	Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol Journal of Molecular Diagnostics ·Ardashel Latsuzbaia, Severien Van Keer, Davy Vanden Broeck, Steven Weyers, Gilbert Donders, P. De Sutter, Wiebren Tjalma, Jean Doyen, Alex Vorsters, Marc Arbyn	2023	19
9	Clinical performance of the novel full‐genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework International Journal of Cancer ·Clementina Cocuzza, Sharonjit K. Dhillon, Marianna Martinelli, Chiara Giubbi, Ruth Chinyere Njoku, Ramya Bhatia, Kate Cuschieri, Marc Arbyn	2023	4
10	The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes Human Vaccines & Immunotherapeutics ·Susan Yuill, Louiza S. Velentzis, Megan A. Smith, Sam Egger, C. David Wrede, Deborah Bateson, Marc Arbyn, Karen Canfell	2021	9
11	Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework Journal of Clinical Pathology ·Ramya Bhatia, Elia Alcañiz Boada, Jesper Bonde, Wim Quint, Lan Xu, Ditte Møller Ejegod, Kate Cuschieri, Marc Arbyn	2021	0
12	Europe's path to eliminating cervical cancer as a public health problem The Lancet Regional Health - Europe ·David Ritchie, Marc Arbyn, Partha Basu, Marilys Corbex, Elena Fidarova, Urška Ivanuš, Ginevra Papi, Julie Torode, Chrysoula Zacharopoulou	2021	3
13	Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework Journal of Clinical Microbiology ·Sharonjit K. Dhillon, Anja Oštrbenk Valenčak, Lan Xu, Mario Poljak, Marc Arbyn	2021	12
14	Invasive cervical cancer following treatment of pre-invasive lesions: A potential theory based on a small case series European Journal of Obstetrics & Gynecology and Reproductive Biology ·Evangelos Paraskevaidis, Antonios Athanasiou, Ilkka Kalliala, Anna Batistatou, Maria Paraskevaidi, Evripidis Bilirakis, Maria Nasioutziki, Minas Paschopoulos, Deirdre Lyons, Marc Arbyn, Margaret Cruickshank, Pierre L. Martin‐Hirsch, Maria Kyrgiou	2021	2
15	Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay Journal of Clinical Virology ·Ina Benoy, Lan Xu, Davy Vanden Broeck, Mario Poljak, Anja Oštrbenk Valenčak, Marc Arbyn, Johannes Bogers	2019	16
16	Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework International Journal of Molecular Sciences ·Lan Xu, Elizaveta Padalko, Anja Oštrbenk, Mario Poljak, Marc Arbyn	2018	28
17	VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples Journal of Clinical Virology ·Marc Arbyn, Eliana Peeters, Ina Benoy, Davy Vanden Broeck, Johannes Bogers, P. De Sutter, Gilbert Donders, Wiebren Tjalma, Steven Weyers, Kate Cuschieri, Mario Poljak, Jesper Bonde, Clementina Cocuzza, Fanghui Zhao, Severien Van Keer, Alex Vorsters	2018	84
18	HPV-FASTER: broadening the scope for prevention of HPV-related cancer Nature Reviews Clinical Oncology ·F. Xavier Bosch, Clàudia Robles, Mireia Díaz, Marc Arbyn, Iacopo Baussano, Christine Clavel, Guglielmo Ronco, Joakim Dillner, Matti Lehtinen, Karl Ulrich Petry, Mario Poljak, Susanne K. Kjær, Chris J.L.M. Meijer, Suzanne M. Garland, Jorge Salmerón, Xavier Castellsagué, Laia Bruni, Silvia de Sanjosé, Jack Cuzick	2015	131
19	METAPROP_ONE: Stata module to perform fixed and random effects meta-analysis of proportions RePEc: Research Papers in Economics ·Victoria Nyawira Nyaga, Marc Arbyn, Marc Aerts	2014	13
20	[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. PubMed ·Guglielmo Ronco, Annibale Biggeri, Massimo Confortini, Carlo Naldoni, N. Segnan, Mario Sideri, Marco Zappa, Manuel Zorzi, Maria Calvia, Gabriele Accetta, Livia Giordano, Carla Cogo, Francesca Maria Carozzi, Anna Gillio‐Tos, Marc Arbyn, Chris J L M Mejier, Peter J.F. Snijders, Jack Cuzick, Paolo Giorgi Rossi	2012	55

About Marc Arbyn

Marc Arbyn is a scholar working on Epidemiology, Microbiology, Obstetrics and Gynecology, Oncology and Urology, having authored 168 papers that have together received 12.9k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (149 papers), Molecular Biology Techniques and Applications (50 papers), Global Cancer Incidence and Screening (42 papers), Genital Health and Disease (33 papers), Hepatitis B Virus Studies (28 papers), Reproductive tract infections research (26 papers), Endometrial and Cervical Cancer Treatments (18 papers) and Colorectal Cancer Screening and Detection (8 papers). The work is most often cited by research in Epidemiology (9.1k citations), Obstetrics and Gynecology (1.8k citations), Microbiology (1.4k citations), Oncology (3.7k citations) and Otorhinolaryngology (378 citations). Marc Arbyn has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Victoria Nyawira Nyaga, Marc Aerts, Freddie Bray, Laia Bruni, Elisabete Weiderpass, Sílvia de Sanjosé, Mona Saraiya, Jacques Ferlay, Peter J.F. Snijders and Nicolas Wentzensen. Their work appears in journals such as Journal of Clinical Virology, International Journal of Cancer, Journal of Clinical Microbiology, Journal of Medical Virology and Journal of Molecular Diagnostics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact